Trial record 1 of 1 for:    NCT01174199
Previous Study | Return to List | Next Study

Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer

This study is currently recruiting participants.
Verified April 2014 by Roswell Park Cancer Institute
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Roswell Park Cancer Institute
ClinicalTrials.gov Identifier:
NCT01174199
First received: July 30, 2010
Last updated: April 14, 2014
Last verified: April 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)